Brian Mueller - 29 Jun 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
29 Jun 2023
Net transactions value
-$869,735
Form type
4
Filing time
30 Jun 2023, 11:35:59 UTC
Previous filing
17 Mar 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Tax liability $409,256 -4,602 -8.3% $88.93 50,983 29 Jun 2023 Direct
transaction BMRN Common Stock Tax liability $409,256 -4,602 -9% $88.93 46,381 29 Jun 2023 Direct
transaction BMRN Common Stock Tax liability $51,224 -576 -1.2% $88.93 45,805 29 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.